Groups | Survival rate % | P value | Survival time, months | |||
---|---|---|---|---|---|---|
Mean | Median | |||||
Estimate ± SE | 95% CI | Estimate ± SE | 95% CI | |||
The 3-years OS% | ||||||
Monocytopenic | 0.00% | 0.076 | 11.7 ± 1.4 | 8.9-14.4 | 16.3 ± 0 | - |
Non-monocytopenic | 13.40% | 9.6 ± 1.5 | 6.6-12.5 | 8.5 ± 2.1 | 4.3–12.7 | |
Overall | 0.00% | 11.2 ± 1.3 | 8.6–13.9 | 10 | 6.9–13.1 | |
The 3-years DFS% | ||||||
Monocytopenic | 41.70% | 0.011 | 11 ± 0.6 | 9.8–12.1 | 12 ± 1.9 | 8.1–15.7 |
Non-monocytopenic | 0.00% | 9 ± 2.5 | 3.5–13.6 | 6 ± 1.2 | 3.5–8.5 | |
Overall | 0.00% | 12.1 ± 1.5 | 9–15.1 | 9.3 ± 1.9 | 5.5–13.1 |